By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


bioMerieux, Inc. 

100 Rodolphe Street

Durham  North Carolina  27712  U.S.A.
Phone: 800-682-2666 Fax: n/a



Gen-Probe Incorporated (Acquired by Hologic)  In September 2004, Gen-Probe entered into non-exclusive licensing agreements with bioMérieux and its affiliates that provide bioMérieux options to access our ribosomal RNA technologies to develop diagnostic products for certain disease targets.

Company News
Sepsis Alliance And bioMerieux, Inc. Partner For Sepsis Awareness And Prevention 4/26/2016 8:44:24 AM
bioMerieux, Inc. And Illumina (ILMN) Announce The Launch Of bioMérieux Episeq, A Revolutionary Next-Generation Sequencing Service For Epidemiological Monitoring Of Bacterial Infections 12/15/2015 11:57:43 AM
LBT Signs Agreement With bioMerieux, Inc. For Previ Isola Automated Plate-Streaking Instrument 8/27/2015 9:48:09 AM
10 Biotech Firms Rapidly Expanding in North Carolina 7/21/2015 5:01:57 AM
bioMerieux, Inc.’s VITEK® MS System Nominated For Prestigious 2014 U.S. Prix Galien Award 10/14/2014 3:03:06 PM
bioMerieux, Inc. Joins With The Rory Staunton Foundation To Host The First National Forum On Sepsis 9/15/2014 10:24:12 AM
ATCC and bioMerieux, Inc. Collaborate To Deliver Accurate Identification Of Industrial Microorganisms 8/22/2014 10:45:57 AM
bioMerieux, Inc.'s THxID®-BRAF Test For Detection Of 2 BRAF Mutations V600E And V600K In Late-Stage Metastatic Melanoma Adopted By Clarient, Inc., A GE Healthcare Company 1/29/2014 10:49:42 AM
Quanterix Raises $18.5 Million, Inks Deal With bioMerieux, Inc. 11/16/2012 7:06:53 AM
Thermo Fisher Scientific (TMO) and bioMerieux, Inc. Renew Partnership for Improved Detection of Sepsis Using PCT Biomarker 10/2/2012 9:54:32 AM